| 000 | 01863 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515034625.0 | ||
| 264 | 0 | _c20070116 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a1538-7933 | ||
| 024 | 7 |
_a10.1111/j.1538-7836.2006.02045.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmith, N L | |
| 245 | 0 | 0 |
_aThe differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _cAug 2006 |
||
| 300 |
_a1701-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aActivated Protein C Resistance _xmetabolism |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aEstrogen Replacement Therapy |
| 650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
| 650 | 0 | 4 |
_aEstrogens, Esterified (USP) _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHemostasis |
| 650 | 0 | 4 | _aHorses |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 |
_aProgestins _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVenous Thrombosis _xprevention & control |
| 700 | 1 | _aHeckbert, S R | |
| 700 | 1 | _aDoggen, C J | |
| 700 | 1 | _aLemaitre, R N | |
| 700 | 1 | _aReiner, A P | |
| 700 | 1 | _aLumley, T | |
| 700 | 1 | _aMeijers, J C M | |
| 700 | 1 | _aPsaty, B M | |
| 700 | 1 | _aRosendaal, F R | |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 4 _gno. 8 _gp. 1701-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1538-7836.2006.02045.x _zAvailable from publisher's website |
| 999 |
_c16468026 _d16468026 |
||